Matrix Trust Co Has $1.85 Million Position in UnitedHealth Group Incorporated $UNH

Key Points

• Matrix Trust Co increased its stake in UnitedHealth Group by 60.9%, acquiring an additional 2,246 shares valued at approximately $1.85 million in the second quarter.
• The company's quarterly earnings reported an EPS of $4.08, falling short of estimates, while the revenue reached $111.62 billion, slightly below expectations.
• UnitedHealth Group declared a quarterly dividend of $2.21, resulting in an annualized dividend yield of 2.6%, with a payout ratio of 38.3%.

Matrix Trust Co boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 60.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,937 shares of the healthcare conglomerate's stock after acquiring an additional 2,246 shares during the period. Matrix Trust Co's holdings in UnitedHealth Group were worth $1,852,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Bayforest Capital Ltd lifted its position in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its position in shares of UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after buying an additional 50 shares during the last quarter. Copia Wealth Management bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $42,000. IAG Wealth Partners LLC purchased a new position in shares of UnitedHealth Group during the first quarter valued at approximately $42,000. Finally, O Brien Wealth Partners LLC increased its stake in UnitedHealth Group by 74.0% in the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock worth $46,000 after acquiring an additional 37 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded up $1.90 during trading on Friday, hitting $336.72. 13,528,738 shares of the stock traded hands, compared to its average volume of 13,684,542. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a market cap of $304.96 billion, a price-to-earnings ratio of 14.59, a P/E/G ratio of 2.20 and a beta of 0.44. The company has a fifty day moving average price of $295.67 and a two-hundred day moving average price of $363.56. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm's revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter last year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the company. Cantor Fitzgerald restated an "overweight" rating and issued a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Barclays increased their target price on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a research note on Thursday, September 4th. JPMorgan Chase & Co. lowered their target price on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a research note on Wednesday, August 6th. Morgan Stanley increased their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a report on Friday, September 12th. Finally, Oppenheimer decreased their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.